tiprankstipranks
Trending News
More News >
Betterlife Pharma Inc. (BETRF)
:BETRF

BetterLife Pharma (BETRF) Price & Analysis

Compare
25 Followers

BETRF Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

36.58%<0.01%63.41%
36.58% Insiders
<0.01% Other Institutional Investors
63.41% Public Companies and
Individual Investors

BETRF FAQ

What was Betterlife Pharma Inc.’s price range in the past 12 months?
Betterlife Pharma Inc. lowest stock price was $0.05 and its highest was $0.15 in the past 12 months.
    What is Betterlife Pharma Inc.’s market cap?
    Betterlife Pharma Inc.’s market cap is $9.58M.
      When is Betterlife Pharma Inc.’s upcoming earnings report date?
      Betterlife Pharma Inc.’s upcoming earnings report date is Jun 25, 2025 which is in 7 days.
        How were Betterlife Pharma Inc.’s earnings last quarter?
        Currently, no data Available
        Is Betterlife Pharma Inc. overvalued?
        According to Wall Street analysts Betterlife Pharma Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Betterlife Pharma Inc. pay dividends?
          Betterlife Pharma Inc. does not currently pay dividends.
          What is Betterlife Pharma Inc.’s EPS estimate?
          Betterlife Pharma Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Betterlife Pharma Inc. have?
          Betterlife Pharma Inc. has 145,494,890 shares outstanding.
            What happened to Betterlife Pharma Inc.’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Betterlife Pharma Inc.?
            Currently, no hedge funds are holding shares in BETRF

            Company Description

            Betterlife Pharma Inc.

            BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
            Similar Stocks
            Company
            Price & Change
            Follow
            Hemostemix
            Kane Biotech
            Britannia Life Sciences Inc
            Resverlogix
            Tetra Bio-Pharma
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis